Course ePortfolio

Surgery Courses

Medical surgery courses from various CME.

Date Added to MERLOT:: January 5, 2019
Created by:: Michael Carmen
License:

Prerequisites

...

Pedagogical Approach & Learning Outcomes

Pedagogical Approach

...

Learning Outcomes

...

Assessment & Other Information

Assessment

...

Other Information

...

Course Resources

Revenue and Reimbursement: Insurance (External link)

Medscape - Dec. 9, 2016 -Dec. 29, 2016 • Judith N. Aburmishan, MBA, CPA, CHBC Director, FGMK, LLC, Bannockburn,... More
Medscape - Dec. 9, 2016 -Dec. 29, 2016 •
- Judith N. Aburmishan, MBA, CPA, CHBC
  
  Director, FGMK, LLC, Bannockburn, Illinois
  
  Disclosure: Judith N. Aburmishan, MBA, CPA, CHBC, has disclosed no relevant financial relationships.
CME Author(s)
- Robert Morris, PharmD
  
  Associate CME Clinical Director, Medscape, LLC
  
  Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.
CME Reviewer(s)
- Amy Bernard, MS, BSN, RN-BC
  
  Lead Nurse Planner, Medscape, LLC
  
  Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.
Reimbursement: New Payment Models (External link)

Medscape - Dec. 30, 2016– Feb. 3, 2017 • Judith N. Aburmishan, MBA, CPA, CHBC Director, FGMK, LLC, Bannockburn,... More
Medscape - Dec. 30, 2016– Feb. 3, 2017 •
- Judith N. Aburmishan, MBA, CPA, CHBC
  
  Director, FGMK, LLC, Bannockburn, Illinois
  
  Disclosure: Judith N. Aburmishan, MBA, CPA, CHBC, has disclosed no relevant financial relationships.
CME Author
- Amy Bernard, MS, BSN, RN-BC
  
  Lead Nurse Planner, Medscape, LLC
  
  Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.
CME Reviewer(s)
- Robert Morris, PharmD
  
  Associate CME Clinical Director, Medscape, LLC
  
  Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.
Negotiating And Getting Paid By Insurers (External link)

Medscape - Feb. 4, 2017 – March 28, 2017 • Judith N. Aburmishan, MBA, CPA, CHBC Director, FGMK, LLC, Bannockburn,... More
Medscape - Feb. 4, 2017 – March 28, 2017 •
- Judith N. Aburmishan, MBA, CPA, CHBC
  
  Director, FGMK, LLC, Bannockburn, Illinois
  
  Disclosure: Judith N. Aburmishan, MBA, CPA, CHBC, has disclosed no relevant financial relationships.
CME Author
- Amy Bernard, MS, BSN, RN-BC
  
  Lead Nurse Planner, Medscape, LLC
  
  Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.
CME Reviewer
- Robert Morris, PharmD
  
  Associate CME Clinical Director, Medscape, LLC
  
  Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.
Medical Practice and the Law (External link)

Medscape - Feb. 6, 2017 - April 7, 2017 • Physicians will gain a foundation in the key legal issues in medicine,... More
Medscape - Feb. 6, 2017 - April 7, 2017 •
Physicians will gain a foundation in the key legal issues in medicine, including the legal entities available for establishing a medical practice, key laws and regulations that affect physicians, and other essential legal issues.

This course covers:
- Legal forms of organization for a medical practice and the pros and cons of each
- Key laws and regulations that affect a medical practice, including the Stark Law governing physician self-referral, the Anti-Kickback Statute, the False Claims Act, HIPAA, and the physician open payments program (the Sunshine Act)
- Business agreements, including debt agreements and other forms of contracts
Reviewed by: Robert A. Bernstein, Esq., LLC, Morristown, New Jersey
Strategy: Running a Successful Business (External link)

Medscape - April 2, 2017 - mAY 29, 2017 • Creating and running a thriving practice involves many factors besides being a... More
Medscape - April 2, 2017 - mAY 29, 2017 •
Creating and running a thriving practice involves many factors besides being a good physician. It’s important for physicians to be able to identify the elements that will help a practice grow or ultimately hinder its success.

This course covers:
- How to develop your mission and vision statements and develop a strategic plan for your business
- How to analyze your market, creating a plan to gain a competitive advantage
- Developing an action plan, measuring success, and evaluating results
- How to support your business strategy and reward performance
Finance: Accounting and Profitability (External link)

Medscape - April 7, 2017 - April 30, 2017 • Understanding and managing finances are important skills that a physician... More
Medscape - April 7, 2017 - April 30, 2017 •
Understanding and managing finances are important skills that a physician needs to keep a practice successful and functioning effectively, and to identify areas of weakness that may hinder financial health.

This course covers:
- Key aspects of financial record-keeping and how to interpret basic financial statements, including balance sheets and income statements
- Tax planning and managing accounts receivable
- Requirements for a basic bookkeeping system and the best ways to track and maintain data
- Using reports to manage your practice, and how to compare against benchmarks to interpret the practice's financial health
- How to implement security for your accounting system, and how to set up internal controls to prevent theft
EHRs: Overcoming the Challenges (External link)

Medscape - June 12, 2017 - Aug. 9, 2017 • Electronic health records (EHRs) have changed the medical world, and the vast... More
Medscape - June 12, 2017 - Aug. 9, 2017 •
Electronic health records (EHRs) have changed the medical world, and the vast majority of physicians use them. But physicians have many questions about how to integrate them into patient care workflow without creating problems.

This course covers:
- Why so many physicians have problems with EHRs, and how to deal with the impact of EHRs on patient relationships
- How to choose between cloud-based versus in-house EHRs
- Current government requirements for using EHRs; and meaningful use, which drove EHR use for years but is being replaced and adapted into new programs and requirements
- Interoperability (EHRs communicating with other offices and healthcare institutions) and its impact on your practice
Using EHRs to Improve Your Practice (External link)

Medscape - jUNE 17, 2017 – Sept. 20, 2017 • EHRs can do much more than simply store data and create a medical record;... More
Medscape - jUNE 17, 2017 – Sept. 20, 2017 •
EHRs can do much more than simply store data and create a medical record; physicians can use the EHR to improve their workflow and work more effectively with patients.

This course covers:
- How to determine whether your EHR provides the patient and charting services needed to meet reporting requirements and streamline your office workflow
- How to identify useful EHR features that physicians most likely are not using
- Effective ways to use the EHR in the hospital and office, as well as the important issue of staff access to EHR data
- Strategies to use with patients who collaborate, and how to monitor the EHR's performance to ensure that it remains effective
Onychomycosis and Diabetes: Patient Case Challenges (External link)

Medscape - July 5, 2017 – Sept.. 12, 2017 • Target Audience and Goal Statement This activity is intended for... More
Medscape - July 5, 2017 – Sept.. 12, 2017 •

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, podiatrists, nurses and other clinicians who manage patients with onychomycosis.

The goal of this activity is to utilize case-based examples to address diagnosis, assessment of comorbidities, and individualizing treatment selection for patients with onychomycosis.

Upon completion of this activity, participants will:
- have increased knowledge regarding the
  - Risks of untreated onychomycosis in the diabetic population
- have greater competence related to
  - The selection of appropriate diagnostic tests for onychomycosis
  - Treatment individualization in patients with diabetes and onychomycosis
Glaucoma: Pearls for Screening, Diagnosis, and Comprehensive Management (External link)

Medscape - June 26, 2017– Sept. 21, 2017 • This activity is intended for ophthalmologists, optometrists, and primary... More
Medscape - June 26, 2017– Sept. 21, 2017 •

This activity is intended for ophthalmologists, optometrists, and primary care physicians.

The goals of this activity are to improve the diagnosis of glaucoma, treatment and adherence to treatment of glaucoma, and outcomes in patients with glaucoma.

Upon completion of this activity, participants will:

have increased knowledge regarding the
- Assessment of patient risk factors for glaucoma
- Diagnosis and evaluation of glaucoma
have greater competence related to
- The selection of appropriate therapies for patients with glaucoma
Addressing a Colleague's Unprofessional Behavior During Sign-Out (External link)

Medscape - Oct. 13, 2017 – Oct. 14, 2017 • Credits Available Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™... More
Medscape - Oct. 13, 2017 – Oct. 14, 2017 •

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion
This article is intended for physicians, hospital practitioners, medical faculty, and other clinicians involved in medical education and training.

The goal of this activity is to describe the need for respect, teamwork, professional integrity, and self-regulation regarding proper sign-out protocol, referring to patients respectfully, and confronting colleagues who deviate from these standards, based on an ACP ethics case study and commentary.

Upon completion of this activity, participants will be able to:
1. Assess the role of professional integrity and the primacy of patient welfare, based on an American College of Physicians ethics case study and commentary
2. Assess the need for patient respect and empathy, and for refraining from derogatory comments
3. Understand and instruct how to deal with colleagues who appear to deviate from these professional standards
Author, Case History

Stephen J. Knohl, MD

Professor, Vice Chair for Education, and Program Director, Department of Medicine, Upstate Medical University, Syracuse, New York

Disclosure: Stephen J. Knohl, MD, has disclosed no relevant financial relationships.

Authors, Commentary

Jessica Mozersky, PhD, MBE

Assistant Professor of Medicine, Washington University School of Medicine, St Louis, Missouri

Disclosure: Jessica Mozersky, PhD, MBE, has disclosed no relevant financial relationships.

Julie R. Rosenbaum, MD, FACP

Associate Professor, Department of Medicine, Yale University School of Medicine; Assistant Director, Adult Primary Care, Yale/Saint Raphael's Adult Primary Care, New Haven, Connecticut

Disclosure: Julie R. Rosenbaum, MD, FACP, has disclosed no relevant financial relationships.

Editor

Lois Snyder Sulmasy, JD

Director, Center for Ethics and Professionalism, American College of Physicians, Philadelphia, Pennsylvania

Disclosure: Lois Snyder Sulmasy, JD, has disclosed no relevant financial relationships.

CME Author

Laurie Barclay, MD

Freelance writer and reviewer, Medscape, LLC

Disclosure: Laurie Barclay, MD, has disclosed the following relevant financial relationships:
Owns stock, stock options, or bonds from: Alnylam; Biogen; Pfizer Inc.

CME Reviewer

Robert Morris, PharmD

Associate CME Clinical Director, Medscape, LLC

Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.
Virtual Patient Simulation: Case Studies in Early Stage HER2+ Breast Cancer (External link)

Medscape - Sept. 21, 2017– Oct. 31, 2017 • CME / ABIM MOC Released: 9/14/2017 Valid for credit through: 9/14/2018 ... More
Medscape - Sept. 21, 2017– Oct. 31, 2017 •
- CME / ABIM MOC Released: 9/14/2017
- Valid for credit through: 9/14/2018
This activity is intended for oncologists and surgeons.

The goal of this activity is to build healthcare professionals’ confidence in the latest strategies for the individualized treatment, care coordination, and follow-up of the patient with early stage HER2+ breast cancer and to ensure that updated and emerging best practices are applied across a variety of clinical settings.

Upon completion of this activity, participants will demonstrate greater performance related to:
- Patient eligibility for neoadjuvant therapy
- Ordering an evidence-based regimen for patients with HER2+ breast cancer
Editor
- Gwen Littman, MD
  
  Scientific Director, Medscape, LLC
  
  Disclosure: Gwen Littman MD, has disclosed no relevant financial relationships.
- Terra M. Sumstine
  
  Managing Editor/Writer, Chichester Associates, Allendale, New Jersey
  
  Disclosure: Terra M. Sumstine has disclosed no relevant financial relationships.
CME Reviewer
- Robert Morris, PharmD
  
  Associate CME Clinical Director, Medscape, LLC
  
  Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.
Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Strategies for Improving Diagnosis And Risk Stratification In Prostate Cancer (External link)

Medscape - Oct. 22, 2017 – Jan. 11, 2018 • CME Released: 10/18/2017 Valid for credit through: 10/18/2018 This... More
Medscape - Oct. 22, 2017 – Jan. 11, 2018 •
- CME Released: 10/18/2017
- Valid for credit through: 10/18/2018
This activity is intended for radiologists, urologists, surgeons, and other healthcare professionals who care for patients with prostate cancer.

The goal of this activity is to increase knowledge about the use of advanced imaging techniques for detection, guiding biopsy, staging, and surveillance of prostate cancer, in order to improve patient outcomes.

Upon completion of this activity, participants will:
- Have increased knowledge regarding the:
  - Factors that lead to an increased risk of prostate cancer
  - Imaging modalities used for prostate cancer screening
  - Imaging modalities that increase the accuracy of biopsy in prostate cancer
  - Detection of disease progression in patients with low-grade prostate cancer undergoing active surveillance
Steering Committee
- Neil M. Rofsky, MD
  
  Professor and Chairman, Radiology, University of Texas Southwestern Medical Center, Dallas, Texas
  
  Disclosure: Neil M. Rofsky, MD, has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Guerbet LLC; Philips Healthcare
- Shreyas S. Vasanawala, MD, PhD
  
  Associate Professor of Radiology, Stanford University, Stanford, California
  
  Disclosure: Shreyas S. Vasanawala, MD, PhD has disclosed the following relevant financial relationships:
  Served as an advisor or consultant for: Arterys
  Received grants for clinical research from: Bayer HealthCare Pharmaceuticals; GE Healthcare
  Owns stock, stock options, or bonds from: Arterys
- Eric Williamson, MD
  
  Professor of Radiology, Mayo Clinic, Rochester, Minnesota
  
  Disclosure: Eric Williamson, MD, has disclosed no relevant financial relationships.
Editor
- Roderick Smith, MS
  
  Scientific Director, Medscape, LLC
  
  Disclosure: Roderick Smith, MS, has disclosed no relevant financial relationships.
CME Reviewer
- Amy Bernard, MS, BSN, RN-BC
  
  Lead Nurse Planner, Medscape, LLC
  
  Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.
Fighting Smarter and Better in GI Cancers: The Role of Immunotherapy (External link)

Medscape - Nov. 16, 2017 – Jan. 26, 2018 Authors: David Ilson, MD, PhD; Dung Le, MD; Katie Bever, MD; Michael J.... More
Medscape - Nov. 16, 2017 – Jan. 26, 2018
- Authors: David Ilson, MD, PhD; Dung Le, MD; Katie Bever, MD; Michael J. Overman, MD
- CME / ABIM MOC Released: 3/21/2017
Target Audience and Goal Statement

This activity is intended for oncologists and gastroenterologists who treat patients with GI cancers.

The goal of this activity is to improve awareness of the latest data on the role of immunotherapy in gastrointestinal (GI) cancers.

Upon completion of this activity, participants will:
- Have increased knowledge of the clinical trial data on immune checkpoint inhibitors in patients with advanced GI cancers
- Have greater knowledge of the potential impact of recent data on treatment for patients with advanced GI cancers
Emerging Approaches to Target the Immunologic Chaos of Graft-vs-Host Disease (External link)

Medscape - Nov. 16, 2017 – Jan. 23, 2018 • Authors: Corey Cutler, MD, MPH; John F. DiPersio, MD, PhD; David Miklos,... More
Medscape - Nov. 16, 2017 – Jan. 23, 2018 •
- Authors: Corey Cutler, MD, MPH; John F. DiPersio, MD, PhD; David Miklos, MD, PhD
- CME Released: 3/29/2017
This activity is intended for hematology/oncology specialists, pathologists, and surgeons.

The goal of this activity is to provide education on the latest developments in the treatment of graft-vs-host disease (GvHD).

Upon completion of this activity, participants will:
- Have increased knowledge regarding the:
  - Patient and clinical features that increase risk for development of GvHD
  - Emerging therapeutic landscape of GvHD
- Have greater competence related to:
  - Integrating optimal therapeutic strategies for the management of GvHD into practice
Optimizing AR and Urticaria Management in APAC: Second-Generation Antihistamines (External link)

Medscape - May 27, 2018 – July 16, 2018 • Authors: Torsten Zuberbier, MD; Martin K. Church, PhD, DSc; Marysia T. Recto,... More
Medscape - May 27, 2018 – July 16, 2018 •

Authors: Torsten Zuberbier, MD; Martin K. Church, PhD, DSc; Marysia T. Recto, MD; Pongsakorn Tantilipikorn, MD, PhD

This educational activity is intended for an international audience of APAC allergists & clinical immunologists, dermatologists, and surgeons.

The goal of this activity is to educate physicians about the unmet needs in managing allergic rhinitis (AR) and urticaria in Asia Pacific (APAC) patients and the use of second-generation antihistamines in clinical practice to improve outcomes for these patients.

Upon completion of this activity, participants will have:
- Increased knowledge regarding the
  - Key clinical challenges in managing Asia Pacific patients with AR and urticaria
  - Clinical data for second-generation antihistamines, particularly in Asia Pacific patients
- Greater competence related to
  - The ability to select appropriate antihistamine therapies for Asia Pacific patients with AR and urticaria to optimize patient outcomes
Management of Head & Neck Cancer at Disease Progression: Now What? (External link)

Medscape - May 21, 2018-Oct. 30, 2018 • Authors: Charu Aggarwal, MD, MPH; Jessica Bauman, MD CME / ABIM MOC Released:... More
Medscape - May 21, 2018-Oct. 30, 2018 •
- Authors: Charu Aggarwal, MD, MPH; Jessica Bauman, MD
- CME / ABIM MOC Released: 12/20/2017
This activity is intended for hematology/oncology specialists, surgeons, and pathologists.

The goal of this activity is to build healthcare professionals’ confidence in strategies for the individualized treatment of the patient with squamous cell carcinoma of the head and neck (SCCHN) that has progressed despite treatment, and to ensure that best practices are applied across a variety of clinical presentations.

Upon completion of this activity, participants will demonstrate improved performance associated with:
- Prescribing the appropriate regimen for a patient with SCCHN based on patient and tumor characteristics
- Ordering patient education for expected treatment-related adverse events
Considerations on Dosing Strategies in Progressive mCRC: Third Line and Beyond (External link)

Medscape - Oct. 31, 2018 – Dec. 12, 2018 • Authors: Tanios Bekaii-Saab, MD; Kelley A. Rone, APRN, CNP, DNP CME / ABIM... More
Medscape - Oct. 31, 2018 – Dec. 12, 2018 •
- Authors: Tanios Bekaii-Saab, MD; Kelley A. Rone, APRN, CNP, DNP
- CME / ABIM MOC Released: 5/31/2018
This activity is intended for oncologists, oncology nurses, and gastroenterologists.

The goal of this activity is to increase clinician awareness and knowledge of practical evidence-based approaches in the management of metastatic CRC (mCRC), including dosing strategies and to aid in translating the latest trial data into clinical practice.

Upon completion of this activity, participants will have:
- Increased knowledge regarding the latest clinical trial data on dosing strategies in the third-line setting to optimize clinical outcomes, including quality of life, in the care of patients with progressive mCRC
- Greater competence related to
  Choosing the most appropriate dosing strategy for patients with progressive mCRC in the third line
  Minimizing the risk of treatment-related adverse events (AEs) in patients with progressive mCRC
  Managing treatment-related AEs in patients with progressive mCRC
  Strategies for open communication between the interprofessional team and patients with progressive mCRC about management of the disease